TREA

79333598 - MBDNA

Follow

Information

  • Trademark
  • 79333598
  • Serial Number
    79333598
  • Filing Date
    September 22, 2021
    3 years ago
  • Transaction Date
    March 04, 2024
    9 months ago
  • Status Date
    February 11, 2023
    a year ago
  • Location Date
    February 11, 2023
    a year ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    BLANE, SUZANNE M
  • Law Office Assigned Location Code
    M50
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
MBDNA
Case File Statements
  • GS0091: Electronic components and applications including wires, semi-conductors including transistors, rectifiers, diodes including light emitting diodes and systems for energy storage such as batteries all comprising of nucleic acids or nucleic acid analogues; parts and fittings for all the aforesaid technology
  • GS0051: Vaccines; DNA based vaccines; DNA extracts, namely, nucleic acid sequences and chemical reagents for medical use; therapeutic DNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acids comprising natural and unnatural nucleotides for medical and veterinary purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for medical and veterinary purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in labelling, imaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in creating nanostructures and scaffolds; nucleic acids comprising natural and unnatural nucleotides for medical and veterinary purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for medical and veterinary purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes; all the aforesaid goods for use in nanotechnology applications including data storage, data retrieval and computing for medical and veterinary purposes; nucleic acids or nucleic acid analogues for labelling, imaging and sensing applications for medical and veterinary purposes; nucleic acids or nucleic acid analogues as smart materials for medical and veterinary purposes; two-dimensional and three-dimensional nucleic acids or nucleic acid analogues for creating nanostructures and scaffolds for medical and veterinary purposes
  • PM0001: MB DNA
  • GS0011: Chemical preparations, enzymes and DNA for the preparation of nucleic acid for scientific research; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for use in agri-biotechnology and nanotechnology; nucleic acids comprising natural and unnatural nucleotides for use in nanotechnology applications including data storage, data retrieval and computing; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for use in nanotechnology applications including data storage, data retrieval and computing; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for use in nanotechnology applications including data storage, data retrieval and computing; nucleic acid analogues with organic and inorganic chemicals for laboratory use in labelling, imaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for laboratory use in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for laboratory use in creating nanostructures and scaffolds; nucleic acids comprising natural and unnatural nucleotides for scientific and research purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for scientific and research purposes; all the aforesaid goods for use in nanotechnology applications including data storage, data retrieval and computing for scientific and research purposes; nucleic acids or nucleic acid analogues for labelling, imaging and sensing applications for scientific and research purposes; nucleic acids or nucleic acid analogues as smart materials for scientific and research purposes; two-dimensional and three-dimensional nucleic acids or nucleic acid analogues for creating nanostructures and scaffolds for scientific and research purposes
Case File Event Statements
  • 3/4/2024 - 9 months ago
    18 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINT
  • 2/12/2024 - 9 months ago
    17 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 2/11/2024 - 9 months ago
    16 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 8/6/2023 - a year ago
    15 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 7/19/2023 - a year ago
    14 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 7/19/2023 - a year ago
    13 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 2/13/2023 - a year ago
    12 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 2/11/2023 - a year ago
    11 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 2/11/2023 - a year ago
    10 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 8/17/2022 - 2 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 7/24/2022 - 2 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/24/2022 - 2 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 6/28/2022 - 2 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/27/2022 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/24/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/26/2022 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/22/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/17/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR